Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19

• Chemotherapy resumption after convalescence from COVID-19 is safe and feasible. • No guidelines exist for resumption of chemotherapy in patients with COVID-19. • Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently.

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol Rep
Main Authors: Liontos, Michalis, Kaparelou, Maria, Karofylakis, Emmanouil, Kavatha, Dimitra, Mentis, Andreas, Zagouri, Flora, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390730/
https://ncbi.nlm.nih.gov/pubmed/32766415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados